Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 10.3389/fphar.2020.00462 Pharmacology Correction Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway Wang Zhengming 1 Wang Yingying 1 Zhu Shan 1 Liu Yao 1 Peng Xin 1 Zhang Shaolu 1 2 Zhang Zhe 1 Qiu Yuling 1 Jin Meihua 1 Wang Ran 1 * Zhong Yuxu 2 * Kong Dexin 1 * 1 Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, China 2 State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

Edited and reviewed by: Zhi Shi, Jinan University, China

*Correspondence: Ran Wang, wangran@tmu.edu.cn; Yuxu Zhong, yuxuzhong2008@aliyun.com; Dexin Kong, kongdexin@tmu.edu.cn

This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology

 08 04 2020 2020 11 462 15 02 2020 24 03 2020 Copyright © 2020 Wang, Wang, Zhu, Liu, Peng, Zhang, Zhang, Qiu, Jin, Wang, Zhong and Kong 2020 Wang, Wang, Zhu, Liu, Peng, Zhang, Zhang, Qiu, Jin, Wang, Zhong and Kong

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway by Wang Z, Wang Y, Zhu S, Liu Y, Peng X, Zhang S, Zhang Z, Qiu Y, Jin M, Wang R, Zhong Y and Kong D (2018). Front. Pharmacol. 9:1450. doi: 10.3389/fphar.2018.01450 DT-13 prostate cancer anti-proliferation anti-metastasis apoptosis PI3K/Akt pathway

In the original article, there was a mistake in Figure 2 as published. The images that represent a minor part of the whole pictures were used in the original published paper. The corrected Figure 2 appears below, with the new images covering over 90% of the whole pictures.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Effect of DT-13 on colony formation capability of prostate cancer cells. (A) Clonogenic assay was carried out to assess the effect of DT-13 on the colony formation capability of PC3 and DU145 cells. After treatment with 0, 2.5, 5, and 10 μM of DT-13 for 48 h, cells were incubated in agarose plates for 14 days and then stained with crystal violet. (B) The histograms represent the number of colonies of PC3 and DU145 cells following treatment with DT-13, compared to those of control cells. Data are mean ± SD (n = 3), representative of three independent experiments. *P< 0.05, **P< 0.01, ***P< 0.001, compared with control.